Drug Utilization Evaluation Study of Ciprofloxacin Utilization and Adverse Events Occurrence in Community Pharmacy Setting: A Cross-Sectional Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 151
- 试验地点
- 1
- 主要终点
- Indications
研究概览
简要总结
Background: Ciprofloxacin is a fluoroquinolone that is commonly used to treat a variety of diseases. Ciprofloxacin resistance is rising, resulting in suboptimal patient care. The goal of this study was to evaluate ciprofloxacin use in the community in terms of acceptable prescription, dose, frequency, and duration of use.
Methods: A cross-sectional research was done in Egyptian community pharmacies by community pharmacists. Patients who were administered oral ciprofloxacin during the research period were included.
详细描述
From September 2021 to February 2022, a cross-sectional, research was undertaken to evaluate ciprofloxacin usage. The investigation was carried out by community pharmacists in seven Egyptian community pharmacies.
Data Collection: data gathered from pharmacy patients' records on a data collection form that included the factors indicated. The General Symptoms Questionnaire, physical examination, and blood testing were used to identify adverse occurrences.
Study variables:
- age, gender, pregnancy/lactation
- Department/indication
- Dose, Frequency, Duration, Adverse events, Drug interactions.
Data was categorized and analyzed using appropriate software.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All ciprofloxacin included prescription during the study period.
排除标准
- •un included ciprofloxacin prescription.
研究组 & 干预措施
Ciprofloxacin
151 record of Ciprofloxacin
干预措施: Ciprofloxacin Tablets (Drug)
结局指标
主要结局
Indications
时间窗: 6 months
Appropriate Indications of ciprofloxacin (frequency )
ciprofloxacin prescription (frequency )
时间窗: 6 months
Number of appropriate ciprofloxacin prescription
adverse events
时间窗: 6 months
adverse events occured during ciprofloxacin therapy (frequency )
次要结局
未报告次要终点
研究者
Rehab Werida
Principal Investigator
Damanhour University